HCA Holdings, Inc. (NYSE:HCA) Price Target Cut to $81.00

HCA Holdings, Inc. (NYSE:HCA) had its price target trimmed by Citigroup Inc. from $87.00 to $81.00 in a report issued on Monday, November 6th, MarketBeat.com reports. The brokerage currently has a neutral rating on the stock.

Other equities analysts also recently issued research reports about the stock. Cantor Fitzgerald reaffirmed a buy rating and set a $95.00 price target on shares of HCA in a research note on Wednesday, September 6th. Argus dropped their price objective on shares of HCA from $100.00 to $93.00 and set a buy rating for the company in a research report on Monday, August 14th. Zacks Investment Research raised shares of HCA from a hold rating to a buy rating and set a $97.00 price objective for the company in a research report on Thursday, July 13th. KeyCorp reissued a buy rating and issued a $95.00 price objective on shares of HCA in a research report on Thursday, September 7th. Finally, Robert W. Baird reissued a buy rating on shares of HCA in a research report on Thursday, September 28th. Two equities research analysts have rated the stock with a sell rating, six have issued a hold rating and seventeen have given a buy rating to the company. The stock has an average rating of Buy and an average target price of $90.20.

HCA (NYSE HCA) opened at $77.19 on Monday. The company has a debt-to-equity ratio of -6.46, a quick ratio of 1.41 and a current ratio of 1.68. The stock has a market cap of $27,329.35, a P/E ratio of 11.71, a P/E/G ratio of 1.14 and a beta of 0.50. HCA has a one year low of $69.59 and a one year high of $91.03.

HCA (NYSE:HCA) last announced its quarterly earnings data on Tuesday, October 31st. The company reported $1.21 earnings per share (EPS) for the quarter, meeting the consensus estimate of $1.21. The business had revenue of $10.70 billion for the quarter, compared to the consensus estimate of $10.70 billion. HCA had a net margin of 6.13% and a negative return on equity of 47.16%. The company’s quarterly revenue was up 4.1% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.45 earnings per share. research analysts forecast that HCA will post 6.55 EPS for the current fiscal year.

In related news, insider Michael S. Cuffe sold 2,150 shares of HCA stock in a transaction dated Tuesday, October 17th. The shares were sold at an average price of $78.00, for a total value of $167,700.00. Following the sale, the insider now directly owns 12,476 shares in the company, valued at approximately $973,128. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, SVP Victor L. Campbell sold 8,000 shares of HCA stock in a transaction dated Thursday, November 16th. The shares were sold at an average price of $75.82, for a total transaction of $606,560.00. Following the completion of the sale, the senior vice president now owns 127,275 shares in the company, valued at $9,649,990.50. The disclosure for this sale can be found here. Over the last quarter, insiders sold 20,300 shares of company stock worth $1,569,981. 2.90% of the stock is currently owned by insiders.

Institutional investors have recently added to or reduced their stakes in the business. Janney Montgomery Scott LLC grew its stake in shares of HCA by 0.4% in the 2nd quarter. Janney Montgomery Scott LLC now owns 3,174 shares of the company’s stock worth $277,000 after purchasing an additional 14 shares during the last quarter. Advisor Partners LLC grew its stake in shares of HCA by 0.3% in the 2nd quarter. Advisor Partners LLC now owns 4,732 shares of the company’s stock worth $413,000 after purchasing an additional 14 shares during the last quarter. Wetherby Asset Management Inc. grew its stake in shares of HCA by 0.6% in the 2nd quarter. Wetherby Asset Management Inc. now owns 4,232 shares of the company’s stock worth $369,000 after purchasing an additional 25 shares during the last quarter. Argent Capital Management LLC grew its stake in shares of HCA by 1.2% in the 2nd quarter. Argent Capital Management LLC now owns 4,370 shares of the company’s stock worth $381,000 after purchasing an additional 50 shares during the last quarter. Finally, Wedbush Securities Inc. grew its stake in shares of HCA by 1.5% in the 2nd quarter. Wedbush Securities Inc. now owns 6,028 shares of the company’s stock worth $526,000 after purchasing an additional 88 shares during the last quarter. 74.63% of the stock is currently owned by hedge funds and other institutional investors.

TRADEMARK VIOLATION WARNING: “HCA Holdings, Inc. (NYSE:HCA) Price Target Cut to $81.00” was originally posted by BBNS and is owned by of BBNS. If you are viewing this article on another publication, it was illegally stolen and reposted in violation of United States & international trademark and copyright legislation. The original version of this article can be viewed at https://baseballnewssource.com/markets/citigroup-inc-trims-hca-holdings-inc-hca-target-price-to-81-00/1762854.html.

About HCA

HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.

Analyst Recommendations for HCA (NYSE:HCA)

Receive News & Ratings for HCA Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Holdings Inc. and related companies with our FREE daily email newsletter.

 


Latest News

Jack Morris, Alan Trammel Voted by Modern Era Committee into Hall of Fame
Jack Morris, Alan Trammel Voted by Modern Era Committee into Hall of Fame
Yankees and Marlins Continue Stanton Trade Talks
Yankees and Marlins Continue Stanton Trade Talks
Marlins Making Moves, Trade Dee Gordon to Seattle
Marlins Making Moves, Trade Dee Gordon to Seattle
Report: Astros Dallas Keuchel Pitched With Injured Foot
Report: Astros Dallas Keuchel Pitched With Injured Foot
Angels Sign Former Prospect with Braves Kevin Maitan
Angels Sign Former Prospect with Braves Kevin Maitan
Shohei Ohtani Has Turned Down Red Sox and Yankees
Shohei Ohtani Has Turned Down Red Sox and Yankees


Leave a Reply

 
© 2006-2017 BBNS.